An amazing number of 278 people from 55 countries (marked in blue on the map) signed up for the OIFE Clinical Trial Update which took place October 22nd, showing that OIFE’s outreach is growing year by year.

In the end we were around 130 participants who received lots of information and updates from the following trials:

• The Cosmic and the Orbit trials (setrusumab)
• EVENITY Ph3 study (romosozumab in children with OI)
• The BoostB4 trial (stem cells)
• The Topaz trial (teriparatide and zolendronate)
• The MOI-A trial (Losartan)
• Osteoanabolic treatment in OI caused by WNT mutations (Germany)
• Project on Paediatric Cross-Border Clinical Trials

Our goal is to publish a written report from the webinar on our website.